A predictive signature for therapy assignment and risk assessment in prostate cancer

Désirée Bonci; Ruggero De Maria Marchiano

doi:10.18632/oncoscience.271

A predictive signature for therapy assignment and risk assessment in prostate cancer

Désirée Bonci
, Ruggero De Maria Marchiano

Istituto Superiore di Sanita

Risultato della ricerca: Contributo in rivista › Articolo › peer review

4 Citazioni (Scopus)

Abstract

Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

Lingua originale	Inglese
pagine (da-a)	920-923
Numero di pagine	4
Rivista	Oncoscience
Volume	2
DOI	https://doi.org/10.18632/oncoscience.271
Stato di pubblicazione	Pubblicato - 2015

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

prostate cancer

Accesso al documento

10.18632/oncoscience.271

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

@article{57ce434524934f029f16a3e13f0d9c82,

title = "A predictive signature for therapy assignment and risk assessment in prostate cancer",

abstract = "Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.",

keywords = "prostate cancer, prostate cancer",

author = "D{\'e}sir{\'e}e Bonci and \{De Maria Marchiano\}, Ruggero",

year = "2015",

doi = "10.18632/oncoscience.271",

language = "English",

volume = "2",

pages = "920--923",

journal = "Oncoscience",

issn = "2331-4737",

publisher = "Impact Journals LLC",

}

TY - JOUR

T1 - A predictive signature for therapy assignment and risk assessment in prostate cancer

AU - Bonci, Désirée

AU - De Maria Marchiano, Ruggero

PY - 2015

Y1 - 2015

N2 - Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

AB - Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

KW - prostate cancer

UR - http://hdl.handle.net/10807/111282

U2 - 10.18632/oncoscience.271

DO - 10.18632/oncoscience.271

M3 - Article

SN - 2331-4737

VL - 2

SP - 920

EP - 923

JO - Oncoscience

JF - Oncoscience

ER -

A predictive signature for therapy assignment and risk assessment in prostate cancer

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo